Minor tobacco alkaloids as biomarkers to distinguish combusted tobacco use from electronic nicotine delivery systems use. two new analytical methods

HIGHLIGHTS

• who: Minor Tobacco Alkaloids as and colleagues from the Clinical Pharmacology Program, Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States have published the research work: Minor Tobacco Alkaloids as Biomarkers to Distinguish Combusted Tobacco Use From Electronic Nicotine Delivery Systems Use. Two New Analytical Methods, in the Journal: (JOURNAL)
• what: The aim of the studies was to develop methods to simultaneously quantify multiple biomarkers useful in studies of dual use of ENDS and combusted cigarettes. The authors propose that anatalline would be a more selective biomarker than . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.